Skip to main content

and
  1. Article

    Open Access

    Distinct gene expression profiles associated with the susceptibility of pathogen-specific CD4+ T cells to HIV-1 infection

    H Hu, M Nau, P Ehrenberg, A Chenine, Z Daye, Z Wei, N Michael, M Vahey in Retrovirology (2012)

  2. Article

    Open Access

    Safety and immunogenicity of a randomized phase I prime-boost trial with ALVAC-HIV (vCP205) and gp160 MN/LAI-2 adjuvanted in alum or polyphosphazene

    RJ O'Connell, VR Polonis, S Ratto-Kim, J Cox, LL Jagodzinski, J Malia in Retrovirology (2012)

  3. Article

    Open Access

    OA04-06 LB. Post-infection cellular immune responses in recipients following ALVAC-HIV® + AIDSVAX® B/E prime-boost vaccination in the Thai Phase III Trial

    JH Kim, C Kamasuta, R Trichavaroj, J Kaewkungwal, S Chantakulkij in Retrovirology (2009)

  4. Article

    Open Access

    OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

    MS de Souza, R Trichavaroj, A Schuetz, W Chuenarom, Y Phuang-ngem in Retrovirology (2009)

  5. Article

    Open Access

    OA04-03. Characterization of cell-mediated immune responses generated by recombinant modified vaccinia Ankara (rMVA)-HIV-1 in a phase I vaccine trial

    JR Currier, M De Souza, S Ratto-Kim, R Paris, V Nguay, J Cox, P Earl in Retrovirology (2009)

  6. Article

    Open Access

    S011-05 OA. HLA-A*7401 is associated with protection from HIV-1 acquisition and disease progression in Mbeya, Tanzania

    RN Koehler, AM Walsh, E Saathoff, JR Currier, CT Bautista, N Moqueet in Retrovirology (2009)